Home › Companies › WEST PHARMACEUTICAL SERVICES INC. › 2024-2025

WEST PHARMACEUTICAL SERVICES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and WEST PHARMACEUTICAL SERVICES INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 18Reported items
  • 714Asset managers
  • 11,530Fund votes
  • 2025-05-06Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore WEST PHARMACEUTICAL SERVICES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by WEST PHARMACEUTICAL SERVICES INC.

These tallies are WEST PHARMACEUTICAL SERVICES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

WEST PHARMACEUTICAL SERVICES INC. — official shareholder meeting results, meeting held 2025-05-06
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Mark A. Buthman 61,532,8021,245,67082,208 --2,153,564 Majority: yes
Elect Director: William F. Feehery 60,733,0342,055,57672,070 --2,153,564 Majority: yes
Elect Director: Robert F. Friel 61,263,5411,514,60182,538 --2,153,564 Majority: yes
Elect Director: Eric M. Green 57,172,1365,326,139362,405 --2,153,564 Majority: yes
Elect Director: Janet B. Haugen 60,548,3122,279,20233,166 --2,153,564 Majority: yes
Elect Director: Thomas W. Hofmann 58,015,3094,679,404165,967 --2,153,564 Majority: yes
Elect Director: Molly E. Joseph 62,289,941530,57640,163 --2,153,564 Majority: yes
Elect Director: Deborah L. V. Keller 55,149,8067,367,368343,506 --2,153,564 Majority: yes
Elect Director: Myla P. Lai-Goldman 61,584,8791,254,54221,259 --2,153,564 Majority: yes
Elect Director: Stephen H. Lockhart 62,513,899264,30882,473 --2,153,564 Majority: yes
Elect Director: Douglas A. Michels 59,815,6982,962,81482,168 --2,153,564 Majority: yes
Elect Director: Paolo Pucci 61,243,7821,534,34482,554 --2,153,564 Majority: yes
Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote: 59,222,3383,516,476121,866 --2,153,564 Majority: yes
Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote: 62,707,01788,40065,263 --2,153,564 Majority: yes
Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote: 60,862,0531,883,395115,232 --2,153,564 Majority: yes
Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote: 60,537,2214,373,036103,987 ---- Majority: yes

Source: WEST PHARMACEUTICAL SERVICES INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the WEST PHARMACEUTICAL SERVICES INC. 2024-2025 meeting

Each item below shows how the 714 asset managers that disclosed a WEST PHARMACEUTICAL SERVICES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of WEST PHARMACEUTICAL SERVICES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 11 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 59,222,338AGAINST: 3,516,476

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 59,222,338 for, 3,516,476 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 82% for, 5% against (87% of the company cast a for/against vote).

The 701 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 95%
FOR: 95.3%AGAINST: 4.7%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,166,4440 00For
BlackRock5,590,7731,980 00For
Fidelity3,269,8970 00For
BROWN ADVISORY INC3,263,5450 00For
State Street2,770,3890 00For
Artisan2,687,7720 00For
Walter Scott & Partners Ltd1,983,7030 00For
GEODE CAPITAL MANAGEMENT, LLC1,822,3130 00For
FRANKLIN ADVISERS INC1,556,6660 00For
APG Asset Management US Inc.01,552,743 00Against
Invesco1,239,343349 00For
T. Rowe Price1,060,6680 00For
Brown Advisory Funds1,043,5510 00For
Charles Schwab963,7470 00For
Calvert877,5470 00For
FRANKLIN MANAGED TRUST858,5000 00For
JPMorgan855,0100 00For
Findlay Park Partners LLP828,6060 00For
Durable Capital Partners LP752,8400 00For
American Century238706,420 00Against
Northern Trust653,2370 00For
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC631,1630 00For
VAN ECK ASSOCIATES CORP603,2350 00For
VanEck ETF Trust601,9390 00For
Neuberger Berman600,1680 00For

Showing the 25 largest of 701 asset managers. See all 701 in the interactive database.

2. Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 60,862,053AGAINST: 1,883,395

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote:”): 60,862,053 for, 1,883,395 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 85% for, 3% against (87% of the company cast a for/against vote).

The 169 asset managers below cast 98% of the shares they voted on this item FOR (26,756,591 for, 496,268 against).

FOR 98%
FOR: 26,756,591 (98.2%)AGAINST: 496,268 (1.8%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century0336,760 00Against
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 169 asset managers. See all 169 in the interactive database.

3. Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting;

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 62,707,017AGAINST: 88,400

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote:”): 62,707,017 for, 88,400 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 87% for, 0.2% against (87% of the company cast a for/against vote).

The 156 asset managers below cast 99.8% of the shares they voted on this item FOR (27,167,402 for, 29,983 against).

FOR 99.8%
FOR: 27,167,402 (99.9%)AGAINST: 29,983 (0.1%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,616668 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

4. Election of Directors: Deborah L. V. Keller

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 55,149,806AGAINST: 7,367,368

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Deborah L. V. Keller”): 55,149,806 for, 7,367,368 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 77% for, 10% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 90% of the shares they voted on this item FOR (24,474,463 for, 2,722,848 against).

FOR 90%10%
FOR: 24,474,463 (90.0%)AGAINST: 2,722,848 (10.0%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Deborah L. V. Keller” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,505779 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST0858,500 00Against
State Street792,8050 00For
VanEck ETF Trust0601,939 00Against
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds0260,256 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

5. Election of Directors: Douglas A. Michels

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 59,815,698AGAINST: 2,962,814

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Douglas A. Michels”): 59,815,698 for, 2,962,814 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 83% for, 4% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 98% of the shares they voted on this item FOR (26,710,898 for, 486,413 against).

FOR 98%
FOR: 26,710,898 (98.2%)AGAINST: 486,413 (1.8%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Douglas A. Michels” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

6. Election of Directors: Eric M. Green

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 57,172,136AGAINST: 5,326,139

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Eric M. Green”): 57,172,136 for, 5,326,139 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 98% of the shares they voted on this item FOR (26,723,387 for, 473,924 against).

FOR 98%
FOR: 26,723,387 (98.3%)AGAINST: 473,924 (1.7%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Eric M. Green” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

7. Election of Directors: Janet B. Haugen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 60,548,312AGAINST: 2,279,202

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Janet B. Haugen”): 60,548,312 for, 2,279,202 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 84% for, 3% against (88% of the company cast a for/against vote).

The 155 asset managers below cast 99.9% of the shares they voted on this item FOR (27,197,260 for, 51 against).

FOR 99.9%
FOR: 27,197,260 (100.0%)AGAINST: 51 (0.0%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Janet B. Haugen” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

8. Election of Directors: Mark A. Buthman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,532,802AGAINST: 1,245,670

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Mark A. Buthman”): 61,532,802 for, 1,245,670 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 86% for, 2% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 99.9% of the shares they voted on this item FOR (27,161,614 for, 25,763 against).

FOR 99.8%
FOR: 27,161,614 (99.9%)AGAINST: 25,763 (0.1%)ABSTAIN: 11,760 (0.0%)
Largest asset managers voting on “Election of Directors: Mark A. Buthman” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

9. Election of Directors: Molly E. Joseph

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 62,289,941AGAINST: 530,576

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Molly E. Joseph”): 62,289,941 for, 530,576 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 87% for, 0.8% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 99.9% of the shares they voted on this item FOR (27,185,590 for, 1,787 against).

FOR 99.9%
FOR: 27,185,590 (100.0%)AGAINST: 1,787 (0.0%)ABSTAIN: 11,760 (0.0%)
Largest asset managers voting on “Election of Directors: Molly E. Joseph” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

10. Election of Directors: Myla P. Lai-Goldman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,584,879AGAINST: 1,254,542

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Myla P. Lai-Goldman”): 61,584,879 for, 1,254,542 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).

The 155 asset managers below cast 99.8% of the shares they voted on this item FOR (27,165,013 for, 32,298 against).

FOR 99.8%
FOR: 27,165,013 (99.9%)AGAINST: 32,298 (0.1%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Myla P. Lai-Goldman” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

11. Election of Directors: Paolo Pucci

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,243,782AGAINST: 1,534,344

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Paolo Pucci”): 61,243,782 for, 1,534,344 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 98% of the shares they voted on this item FOR (26,737,605 for, 459,706 against).

FOR 98%
FOR: 26,737,605 (98.3%)AGAINST: 459,706 (1.7%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Paolo Pucci” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

12. Election of Directors: Robert F. Friel

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,263,541AGAINST: 1,514,601

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Robert F. Friel”): 61,263,541 for, 1,514,601 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 98% of the shares they voted on this item FOR (26,737,605 for, 459,706 against).

FOR 98%
FOR: 26,737,605 (98.3%)AGAINST: 459,706 (1.7%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Robert F. Friel” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

13. Election of Directors: Stephen H. Lockhart

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 62,513,899AGAINST: 264,308

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Stephen H. Lockhart”): 62,513,899 for, 264,308 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 87% for, 0.4% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 99.9% of the shares they voted on this item FOR (27,197,260 for, 51 against).

FOR 99.9%
FOR: 27,197,260 (100.0%)AGAINST: 51 (0.0%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Stephen H. Lockhart” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

14. Election of Directors: Thomas W. Hofmann

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 58,015,309AGAINST: 4,679,404

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Thomas W. Hofmann”): 58,015,309 for, 4,679,404 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 81% for, 7% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 99.7% of the shares they voted on this item FOR (27,122,583 for, 74,728 against).

FOR 99.7%
FOR: 27,122,583 (99.7%)AGAINST: 74,728 (0.3%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: Thomas W. Hofmann” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

15. Election of Directors: William F. Feehery

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 60,733,034AGAINST: 2,055,576

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: William F. Feehery”): 60,733,034 for, 2,055,576 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 85% for, 3% against (87% of the company cast a for/against vote).

The 155 asset managers below cast 99.8% of the shares they voted on this item FOR (27,169,820 for, 27,491 against).

FOR 99.8%
FOR: 27,169,820 (99.9%)AGAINST: 27,491 (0.1%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Election of Directors: William F. Feehery” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

16. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm FOR 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-06.

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 60,537,221AGAINST: 4,373,036

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote:”): 60,537,221 for, 4,373,036 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 84% for, 6% against (90% of the company cast a for/against vote).

The 153 asset managers below cast 99.6% of the shares they voted on this item FOR (27,076,832 for, 105,494 against).

FOR 99.6%
FOR: 27,076,832 (99.6%)AGAINST: 105,494 (0.4%)ABSTAIN: 1,826 (0.0%)
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting ” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
JPMorgan318,0490 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 153 asset managers. See all 153 in the interactive database.

17. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-04-23 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 61,974,315AGAINST: 2,926,263

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 61,974,315 for, 2,926,263 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 71,800,000 outstanding shares: 86% for, 4% against (90% of the company cast a for/against vote).

The 3 asset managers below cast 16% of the shares they voted on this item FOR (95 for, 516 against).

FOR 16%AGAINST 84%
FOR: 95 (15.5%)AGAINST: 516 (84.5%)
Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC0516 00Against
Ipswich Investment Management Co., Inc.950 00For
Echo45 Advisors LLC00 00--

18. Ratification of Auditor

AUDIT-RELATED

Meeting held 2025-05-06.

17% fund support · no official result

FOR 17%AGAINST 83%

The 3 asset managers below cast 17% of the shares they voted on this item FOR (2,624 for, 12,435 against).

FOR: 2,624 (17.4%)AGAINST: 12,435 (82.6%)
Largest asset managers voting on “Ratification of Auditor” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.012,435 00Against
AMERICAN BEACON FUNDS2,5500 00For
NORTHERN LIGHTS FUND TRUST III740 00For

Largest WEST PHARMACEUTICAL SERVICES INC. shareholders voting in 2024-2025

Ranked by the number of WEST PHARMACEUTICAL SERVICES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 71,800,000 shares outstanding at the time of that meeting.

Top WEST PHARMACEUTICAL SERVICES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.77%
2BlackRock 7.79%
3Fidelity 4.55%
4BROWN ADVISORY INC 4.55%
5State Street 3.86%
6Artisan 3.74%
7Walter Scott & Partners Ltd 2.76%
8GEODE CAPITAL MANAGEMENT, LLC 2.54%
9FRANKLIN ADVISERS INC 2.17%
10APG Asset Management US Inc. 2.16%

Reported WEST PHARMACEUTICAL SERVICES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

WEST PHARMACEUTICAL SERVICES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Vanguard Group 12.86% 13F
BlackRock 9.65% 13F
BNY Mellon 4.70% 13F
State Street 4.46% 13F
Geode Capital 2.58% 13F
Franklin Templeton 2.17% 13F
Morgan Stanley 1.79% 13F
Invesco 1.32% 13F
Norges Bank 1.25% 13F
Northern Trust 1.06% 13F

Percentages above are of 71,800,000 shares outstanding, as reported by WEST PHARMACEUTICAL SERVICES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from WEST PHARMACEUTICAL SERVICES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At WEST PHARMACEUTICAL SERVICES INC.'s shareholder meeting held 2025-05-06, in the 2024-2025 proxy season, 714 asset managers reported how they voted in their SEC Form N-PX filings, covering 11,530 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: WEST PHARMACEUTICAL SERVICES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

WEST PHARMACEUTICAL SERVICES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.